Zhejiang Jingxin Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Zhejiang Jingxin Pharmaceutical Co Ltd cash flow reinvestment rate. Zhejiang Jingxin Pharmaceutical Co Ltd (002020) has a Cash Flow Reinvestment Rate of 0.16x as of September 2025, reinvesting CN¥35.55 Million (capex CN¥35.55 Million ) from operating cash flow of CN¥227.64 Million. Explore 002020 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Zhejiang Jingxin Pharmaceutical Co Ltd (2002–2025)
Cash flow reinvestment rate of Zhejiang Jingxin Pharmaceutical Co Ltd from 2002 to 2025. Historical reinvestment intensity for Zhejiang Jingxin Pharmaceutical Co Ltd across 22 annual periods. Explore how much does Zhejiang Jingxin Pharmaceutical Co Ltd reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Zhejiang Jingxin Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2002–2025)
Zhejiang Jingxin Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2002 to 2025. Year-by-year capital reinvestment analysis for Zhejiang Jingxin Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 002020 cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.98x | CN¥768.92 Million | CN¥781.35 Million | CN¥202.85 Million | ▼ -50.0% |
| 2024 | 1.97x | CN¥1.43 Billion | CN¥726.16 Million | CN¥250.65 Million | ▲ +29.1% |
| 2023 | 1.52x | CN¥1.26 Billion | CN¥824.69 Million | CN¥519.51 Million | ▲ +52.0% |
| 2022 | 1.00x | CN¥857.97 Million | CN¥855.78 Million | CN¥515.57 Million | ▼ -59.9% |
| 2021 | 2.50x | CN¥912.77 Million | CN¥365.02 Million | CN¥404.43 Million | ▲ +23.2% |
| 2020 | 2.03x | CN¥1.04 Billion | CN¥513.21 Million | CN¥334.00 Million | ▲ +196.3% |
| 2019 | 0.68x | CN¥366.65 Million | CN¥535.30 Million | CN¥337.33 Million | ▲ +45.5% |
| 2018 | 0.47x | CN¥246.39 Million | CN¥523.40 Million | CN¥242.19 Million | ▼ -86.4% |
| 2017 | 3.45x | CN¥1.33 Billion | CN¥385.01 Million | CN¥112.19 Million | ▲ +68.1% |
| 2016 | 2.05x | CN¥519.01 Million | CN¥252.69 Million | CN¥95.26 Million | ▲ +96.8% |
| 2015 | 1.04x | CN¥151.04 Million | CN¥144.69 Million | CN¥114.31 Million | ▲ +131.9% |
| 2014 | 0.45x | CN¥94.75 Million | CN¥210.49 Million | CN¥94.75 Million | ▼ -53.8% |
| 2013 | 0.98x | CN¥108.28 Million | CN¥111.03 Million | CN¥108.28 Million | ▼ -29.6% |
| 2012 | 1.39x | CN¥83.51 Million | CN¥60.28 Million | CN¥83.51 Million | ▲ +33.8% |
| 2011 | 1.04x | CN¥71.86 Million | CN¥69.41 Million | CN¥71.86 Million | ▼ -60.4% |
| 2010 | 2.62x | CN¥155.87 Million | CN¥59.55 Million | CN¥155.87 Million | ▲ +1655.7% |
| 2009 | 0.15x | CN¥20.18 Million | CN¥135.38 Million | CN¥20.18 Million | ▼ -89.8% |
| 2008 | 1.46x | CN¥43.81 Million | CN¥29.98 Million | CN¥43.81 Million | ▼ -32.9% |
| 2005 | 2.18x | CN¥134.67 Million | CN¥61.82 Million | CN¥134.67 Million | ▼ -85.7% |
| 2004 | 15.26x | CN¥98.11 Million | CN¥6.43 Million | CN¥98.11 Million | ▲ +889.6% |
| 2003 | 1.54x | CN¥71.19 Million | CN¥46.18 Million | CN¥71.19 Million | ▲ +46.8% |
| 2002 | 1.05x | CN¥47.79 Million | CN¥45.50 Million | CN¥47.79 Million | — |